1-7 of 7
Jacob Zighelboim
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Intraperitoneal Administration of Human Recombinant Interferon-α in Patients with Ovarian Cancer: Effects on Lymphocyte Phenotype and Cytotoxicity

Free
Alan Lichtenstein, Celsa Spina, Jonathan S. Berek, Tyler Jung, Jacob Zighelboim
Journal: Cancer Research
Cancer Res (1988) 48 (20): 5853–5859.
Published: 01 October 1988
View articletitled, Intraperitoneal Administration of Human Recombinant Interferon-α in Patients with Ovarian Cancer: Effects on Lymphocyte Phenotype and Cytotoxicity
Open the PDF for Intraperitoneal Administration of Human Recombinant Interferon-α in Patients with Ovarian Cancer: Effects on Lymphocyte Phenotype and Cytotoxicity in another window
Journal Articles

Synergistic Effects of Combination Sequential Immunotherapies in a Murine Ovarian Cancer Model

Free
Jonathan S. Berek, Alan K. Lichtenstein, Reba M. Knox, Tyler S. Jung, Thanne P. Rose, John L. Cantrell, Jacob Zighelboim
Journal: Cancer Research
Cancer Res (1985) 45 (9): 4215–4218.
Published: 01 September 1985
View articletitled, Synergistic Effects of Combination Sequential Immunotherapies in a Murine Ovarian Cancer Model
Open the PDF for Synergistic Effects of Combination Sequential Immunotherapies in a Murine Ovarian Cancer Model in another window
Journal Articles

Intraperitoneal Recombinant α-Interferon for “Salvage” Immunotherapy in Stage III Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study

Free
Jonathan S. Berek, Neville F. Hacker, Alan Lichtenstein, Tyler Jung, Celsa Spina, Reba M. Knox, Jeanine Brady, Teri Greene, Lupe M. Ettinger, Leo D. Lagasse, Eric M. Bonnem, Robert J. Spiegel, Jacob Zighelboim
Journal: Cancer Research
Cancer Res (1985) 45 (9): 4447–4453.
Published: 01 September 1985
View articletitled, Intraperitoneal Recombinant α-Interferon for “Salvage” Immunotherapy in Stage III Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study
Open the PDF for Intraperitoneal Recombinant α-Interferon for “Salvage” Immunotherapy in Stage III Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study in another window
Journal Articles

Role of Inflammatory Neutrophils in Antitumor Effects Induced by Intraperitoneal Administration of Corynebacterium parvum in Mice

Free
Alan K. Lichtenstein, Jonathan Berek, Janet Kahle, Jacob Zighelboim
Journal: Cancer Research
Cancer Res (1984) 44 (11): 5118–5123.
Published: 01 November 1984
View articletitled, Role of Inflammatory Neutrophils in Antitumor Effects Induced by Intraperitoneal Administration of Corynebacterium parvum in Mice
Open the PDF for Role of Inflammatory Neutrophils in Antitumor Effects Induced by Intraperitoneal Administration of Corynebacterium parvum in Mice in another window
Journal Articles

Immunotherapy with Biochemically Dissociated Fractions of Propionibacterium acnes in a Murine Ovarian Cancer Model

Free
Jonathan S. Berek, John L. Cantrell, Alan K. Lichtenstein, Neville F. Hacker, Reba M. Knox, Roberta K. Nieberg, Thanne Poth, Robert M. Elashoff, Leo D. Lagasse, Jacob Zighelboim
Journal: Cancer Research
Cancer Res (1984) 44 (5): 1871–1875.
Published: 01 May 1984
View articletitled, Immunotherapy with Biochemically Dissociated Fractions of Propionibacterium acnes in a Murine Ovarian Cancer Model
Open the PDF for Immunotherapy with Biochemically Dissociated Fractions of Propionibacterium acnes in a Murine Ovarian Cancer Model in another window
Journal Articles

Inhibition of Natural Killer Cell Activity by a Soluble Substance Released by Rat Peritoneal Cells

Free
Jacob Zighelboim, Alan Lichtenstein, Aron Bick, Robert Mickel
Journal: Cancer Research
Cancer Res (1983) 43 (5): 1984–1989.
Published: 01 May 1983
View articletitled, Inhibition of Natural Killer Cell Activity by a Soluble Substance Released by Rat Peritoneal Cells
Open the PDF for Inhibition of Natural Killer Cell Activity by a Soluble Substance Released by Rat Peritoneal Cells in another window
Journal Articles

Deficiency of Antibody-dependent Cellular Cytotoxicity and Mitogen-induced Cellular Cytotoxicity Effector Cell Function in Patients with Acute Myelogenous Leukemia in Remission

Free
Jacob Zighelboim
Journal: Cancer Research
Cancer Res (1979) 39 (9): 3357–3362.
Published: 01 September 1979
View articletitled, Deficiency of Antibody-dependent Cellular Cytotoxicity and Mitogen-induced Cellular Cytotoxicity Effector Cell Function in Patients with Acute Myelogenous Leukemia in Remission
Open the PDF for Deficiency of Antibody-dependent Cellular Cytotoxicity and Mitogen-induced Cellular Cytotoxicity Effector Cell Function in Patients with Acute Myelogenous Leukemia in Remission in another window